More than 7,500 students with Type 1 diabetes enter college every year, and the number is only growing. At the University of ...
FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
Hosted on MSN1d
What is an artificial pancreas?An artificial pancreas combines a glucose monitor with an insulin pump. In this video, Griffin Rodgers, MD, director of ...
One of the key launch points for the modern biotechnology industry was not in the Bay Area or San Diego or Cambridge, ...
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback